Schedule 13G/A
MOR2 Schedule 13G/A filing by T. Rowe Price Investment Management
T. Rowe Price Investment Management reported beneficial ownership of 6.4M shares, representing 4.3% of MORPHOSYS AG ADR in this filing.
FiledFeb 16, 2024
Ownership dateDec 31, 2023
Reported shares6.4M
Reported ownership4.3%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
1.9M
Shared voting power
0
Sole dispositive power
6.4M
Shared dispositive power
0
Compared with the prior filing
How the reported position changed
This compares the current filing with the previous tracked Schedule 13 filing from the same reporting CIK for MOR2. A change between filings does not by itself establish when shares were bought or sold.
Previous filingFeb 14, 2024
Reported share change0
Ownership percentage change0 pts
| Previous filing | This filing | |
|---|---|---|
| Reported shares | 6.4M | 6.4M |
| Reported ownership | 4.3% | 4.3% |
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- T. Rowe Price Investment Management
- CIK
- CIK0001897612
- Accession
- 0001897612-24-001341
- Form
- Schedule 13G/A
Read the filing in context